52 • S U P P L E M E N T
T O O U T P A T I E N T S U R G E R Y M A G A Z I N E • D E C E M B E R 2 0 2 0
SPECIAL ADVERTISING SUPPLEMENT
Meet the Smallest Knotless Anchor
on the Market
Just pass it, cinch it, cut it, and save time—and eliminate the
risk of knot impingement and migration with the simple,
reproducible insertion and passing technique of Arthrex's
Knotless 1.8 FiberTak Soft Anchor. This anchor is at the
forefront of tensionable knotless technology. Suture tension
can be controlled and adjusted under direct visualization, with
48 pounds of secure, low-profile knotless suture fixation.
Curved and straight guide delivery systems are available with
1.8-mm drills.
For more information, visit www.Arthrex.com
Finally, a Proven, Minimally Invasive
Approach to BPH
Benign prostatic hyperplasia (BPH) affects millions of men, and
many patients seek a minimally invasive alternative to major
surgical treatment or to medications, which are discontinued by
a third of BPH patients due to bothersome side effects and
insufficient relief. Teleflex's FDA-approved UroLift System for
Prostatic Urethral Lift is that alternative: a minimally invasive
approach to BPH, performed in outpatient or inpatient settings
under general or local anesthesia. The UroLift System consists
of the UroLift Delivery Device, inserted transurethrally, and the
UroLift Implants, permanent implants deployed by the delivery
device to hold obstructing prostatic lobes apart. Learn more
about the UroLift System for BPH relief.
For more information, visit www.UroLift.com/info
U R O L O G Y
You Can Be Confident in These Ophthalmology
and Urology Medications
EDGE Pharma is a pharmaceutical sterile and non-sterile 503B
Outsourcing Facility offering high quality innovative solutions for
the healthcare community. Available ophthalmic medications
include hyaluronidase ophthalmic blocks (bupivacaine/lido-
caine/hyaluronidase and epinephrine/lidocaine/hyaluronidase) in
premixed, ready-to-administer retrobulbar and peribulbar
ophthalmic blocks dispensed in unit-dose syringes; povidone
iodine, mitomycin ophthalmic and EDTA; and epi-shugarcaine
dilating injections in unit-dose syringes. EDGE Pharma also
offers these urology medications in ready-to-administer kits,
prefilled unit-dose Luer Lock syringes with the CSTD pre-
attached: the new gemcitabine bladder instillation kit (1 g/50 mL)
and the mitomycin bladder instillation kit (40 mg/40 mL).
For more information, call (802) 992-1178 or visit www.edgepharma
